Business Description
BriaCell Therapeutics Corp. is a Canadian cancer treatment company focused on creating new ways to help the immune system fight tumors. Its most advanced program, Bria-IMT, is currently in Phase 3 trials for late-stage breast cancer, while other treatments in development aim to target a broader range of cancer types. The company works with leading research partners, including a collaboration with MSK Accelerator and a licensing agreement with the University of Maryland Baltimore County, to bring its therapies to patients faster.
